- News- Week-old COVID-19 urology guidelines already outdated- March 25, 2020- Recommendations for treating patients during the COVID-19 pandemic are changing rapidly. 
![1]() - News- FDA issues warning on fecal transplant transmission of SARS-CoV-2- March 25, 2020- The FDA has issued several recommendations for any medically necessary usage of fecal microbiota transplantation. 
- News- AGA and colleague societies issue clinical insights for COVID-19- March 19, 2020- Screening patients, personal protection, procedure postponement, and special precautions with infected patients are discussed. 
- News- Potential GI manifestation, transmission of coronavirus- March 17, 2020- The virus appears to infect and could potentially spread through the gastrointestinal route. 
- News- COVID-19: Older patients with cancer especially vulnerable- March 12, 2020- Expert advises diligence in screening cancer patients and commonsense preventative measures. 
- News- Early GI symptoms in COVID-19 may indicate fecal transmission- March 12, 2020- The discovery is preliminary. “There is evidence of the virus in stool, but not evidence of infectious virus.” 
- News- ‘Momentous’ USMLE change: New pass/fail format stuns medicine- February 19, 2020- Step 1 had been criticized as playing too big a role in the process of becoming a physician and for causing students to study for the test instead of engaging fully in their medical education. 
![1]() - News- Updated international consensus recommendations on management of acute upper GI bleeding- October 21, 2019- Updated guidelines on management of nonvariceal acute upper GI bleeding address questions on endoscopic techniques and pharmacologic management. 
![1]() - News- Older IBD patients are most at risk of postdischarge VTE- September 10, 2019- Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge. 
![1]() - News- Rivaroxaban tied to higher GI bleeding than other NOACs- June 17, 2019- SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited. 



